Nav: Home

Second cancers deadlier in young patients

April 20, 2017

Second cancers in children and adolescents and young adults (AYA) are far deadlier than they are in older adults and may partially account for the relatively poor outcomes of cancer patients ages 15-39 overall, a new study by UC Davis researchers has found.

The study also found that survival after almost all types of cancer is much higher when the cancer occurs as a primary malignancy than if it is a second cancer, and these survival differences are most pronounced in patients under age 40. The article, entitled "Second Primary Malignant Neoplasms and Survival in Adolescent and Adult Cancer Survivors," is published today in JAMA Oncology.

Based on an analysis of more than 1 million cancer patients of all ages from throughout the U.S., the study is the first to compare survival after a second cancer to survival of the same cancer that occurs as the first primary malignancy, by age. Researchers hope the findings help guide clinicians in providing age-specific recommendations on cancer prevention, screening, treatment and survivorship, especially among the AYA population for whom survival rates have not improved to the same extent as they have for children and older adults.

"Although the increased incidence of second cancers is well known among cancer survivors, less is known about outcomes of these cancers or the influence of age," said Theresa Keegan, a cancer epidemiologist at the UC Davis Comprehensive Cancer Center and the study's lead author.

Keegan and colleagues at UC Davis, Oregon Health and Science University and the John Wayne Cancer Institute identified all patients diagnosed with only one or a first and second malignancy during 1992 through 2008 using Surveillance, Epidemiology and End Results (SEER) program data collected from 13 cancer registries. The researchers were careful not to capture recurrences of the same cancer when identifying secondary malignancies.

The authors collected data on the 14 most common cancer types that affect AYAs: female breast, thyroid, testicular, Hodgkin lymphoma, non-Hodgkin lymphoma, acute lymphoblastic leukemia, acute myeloid leukemia, soft tissue sarcoma, bone sarcoma, colorectal, central nervous system, cervical and ovarian cancer.

Overall, children and AYAs had an 80 percent chance of surviving five years after a diagnosis of a first cancer. But if the same cancer occurred as a secondary malignancy, 5-year survival dropped to 47 percent for children and 60 percent for the AYA population. The differences in survival were not nearly as marked in the older adult population, who had a 70 percent chance of surviving five years overall for a first cancer and 61 percent for a new, second malignancy.

When the researchers looked at 5-year survival by age and individual cancer types, they found striking differences depending on whether it was a first or secondary malignancy in all but two of the 14 cancer types, testes and melanoma.

"For almost every type of cancer, the AYA population did worse with a secondary cancer," said Melanie Goldfarb, an endocrine surgeon at John Wayne Cancer Institute and co-author on the study. "What struck us was that the second cancer caused such an increased risk of death."

For example, AYA patients diagnosed with acute myeloid leukemia as a first cancer had a 57 percent chance of surviving for five years, but that dropped to 29 percent if it was the second cancer. For AYA patients diagnosed with breast cancer, the 5-year survival was 81 percent for a first cancer but 63 percent if it was a second cancer.

Why younger patients tend to fare worse than older patients with the same second cancers is not fully understood or specifically addressed in the current study, the authors said.

Keegan said an explanation for worse outcomes may be that those with a secondary cancer have a worse response to treatment, limitations on the types or doses of treatments that they can receive as a result of their prior cancer treatment or impaired physiologic reserves that impact their ability to tolerate treatment.

Goldfarb added that psycho-social issues may play an important role, or combine with other factors such as an underlying biological condition that predisposes someone to cancer.

"These younger people don't have all the support or resources they need," she said. "They may not have adequate insurance, or they may get lost in the system. They may suffer from depression, which can contribute to their overall health and worsen their cancer outcome."

The authors plan next to examine how the time between getting a first and second cancer affects survival and whether the type of treatment for the first cancer influences the outcome of a second cancer.
Other researchers on the study were Archie Bleyer Oregon Health and Science University and Aaron S. Rosenberg and Qian Li of UC Davis.

To view the article, see Second Primary Malignant Neoplasms and Survival in Adolescent and Adult Cancer Survivors.

University of California - Davis Health System

Related Cancer Articles:

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.
Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.
Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.
Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.
More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.
New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.
American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.
Oncotarget: Cancer pioneer employs physics to approach cancer in last research article
In the cover article of Tuesday's issue of Oncotarget, James Frost, MD, PhD, Kenneth Pienta, MD, and the late Donald Coffey, Ph.D., use a theory of physical and biophysical symmetry to derive a new conceptualization of cancer.
Health indicators for newborns of breast cancer survivors may vary by cancer type
In a study published in the International Journal of Cancer, researchers from the UNC Lineberger Comprehensive Cancer Center analyzed health indicators for children born to young breast cancer survivors in North Carolina.
Few women with history of breast cancer and ovarian cancer take a recommended genetic test
More than 80 percent of women living with a history of breast or ovarian cancer at high-risk of having a gene mutation have never taken the test that can detect it.
More Cancer News and Cancer Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

There's so much we've yet to explore–from outer space to the deep ocean to our own brains. This hour, Manoush goes on a journey through those uncharted places, led by TED Science Curator David Biello.
Now Playing: Science for the People

#555 Coronavirus
It's everywhere, and it felt disingenuous for us here at Science for the People to avoid it, so here is our episode on Coronavirus. It's ok to give this one a skip if this isn't what you want to listen to right now. Check out the links below for other great podcasts mentioned in the intro. Host Rachelle Saunders gets us up to date on what the Coronavirus is, how it spreads, and what we know and don't know with Dr Jason Kindrachuk, Assistant Professor in the Department of Medical Microbiology and infectious diseases at the University of Manitoba. And...
Now Playing: Radiolab

Dispatch 1: Numbers
In a recent Radiolab group huddle, with coronavirus unraveling around us, the team found themselves grappling with all the numbers connected to COVID-19. Our new found 6 foot bubbles of personal space. Three percent mortality rate (or 1, or 2, or 4). 7,000 cases (now, much much more). So in the wake of that meeting, we reflect on the onslaught of numbers - what they reveal, and what they hide.  Support Radiolab today at